Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proteomic Assessment of Preterm Birth

NCT01371019 is registered in ClinicalTrials.gov with Sera Prognostics, Inc. as lead sponsor.

NCT NCT01371019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01371019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proteomic Assessment of Preterm Birth
Lead sponsor
Sera Prognostics, Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
April 30, 2015
Enrollment
5,500 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

preterm birth